NCT06393062 Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy
| NCT ID | NCT06393062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adiyaman University |
| Condition | Percutaneous Nephrolithotomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 245 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 245 participants in total. It began in 2022-12-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.
Eligibility Criteria
Inclusion Criteria: * patients with an indication for percutaneous nephrolithotomy due to kidney stone disease. Exclusion Criteria: * under 18 years old, * having an active urinary tract infection before surgery and positive urine cultures, * Patients with bilateral kidney stones, * DJ stent or nephrostomy placement, * Solitary kidney stones, * Bleeding disorders, * impaired kidney function, * a history of antibiotic use for any reason within 2 weeks before randomization were excluded from the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06393062 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Percutaneous Nephrolithotomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06393062 currently recruiting?
Yes, NCT06393062 is actively recruiting participants. Contact the research team at bedreddin84@windowslive.com for enrollment information.
Where is the NCT06393062 trial being conducted?
This trial is being conducted at Adıyaman, Turkey (Türkiye).
Who is sponsoring the NCT06393062 clinical trial?
NCT06393062 is sponsored by Adiyaman University. The trial plans to enroll 245 participants.